Vident Investment Advisory’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,056	Closed	-$522K	–	1287
2023 Q1	$522K	Sell	11,056 -79	-0.7%	-$3.73K	0.02%	766
2022 Q4	$773K	Buy	11,135 +4,522	+68%	+$314K	0.03%	556
2022 Q3	$969K	Sell	6,613 -708	-10%	-$104K	0.03%	602
2022 Q2	$955K	Buy	+7,321	New	+$955K	0.03%	637